Axatilimab + CAR-T for High-Risk Lymphoma
Axatilimab + CAR-T for High-Risk Lymphoma
Not yet recruiting · NCT07638982 · Registry updated 2026-06-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Axatilimab + CAR-T for High-Risk Lymphoma | B-cell neoplasm, Digestive System Diseases, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, digestive system disorder, follicular lymphoma, hypertrophic pyloric stenosis, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, pyloric stenosis, stomach disorder | Not yet recruiting | Phase 1 | 2026-06-10 | NCT07638982 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Northside Hospital, Inc. | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Northside Hospital | Atlanta | United States | 134 |